California State Teachers Retirement System (CalSTRS)’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-55,534
Closed -$1.16M 3004
2016
Q3
$1.16M Buy
55,534
+400
+0.7% +$4.61K ﹤0.01% 1974
2016
Q2
$595K Buy
55,134
+26,633
+93% +$228K ﹤0.01% 2358
2016
Q1
$189K Buy
28,501
+3,887
+16% +$35.4K ﹤0.01% 2821
2015
Q4
$446K Sell
24,614
-174,234
-88% -$2.4M ﹤0.01% 2502
2015
Q3
$2.19M Buy
198,848
+174,621
+721% +$1.86M 0.01% 1471
2015
Q2
$349K Buy
24,227
+12,227
+102% +$166K ﹤0.01% 2787
2015
Q1
$141K Buy
12,000
+1,600
+15% +$21.6K ﹤0.01% 2934
2014
Q4
$173K Buy
+10,400
New +$152K ﹤0.01% 2943

California State Teachers Retirement System (CalSTRS)'s VTAE Position: Q4 2016 in Review

California State Teachers Retirement System (CalSTRS) sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 55,534 shares — an estimated $1.16M sold.

California State Teachers Retirement System (CalSTRS) first reported a position in VTAE in Q4 2014 and held it in 8 quarters. The position peaked at $2.19M in Q3 2015. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • California State Teachers Retirement System (CalSTRS) reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 55,534 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.16M.
  • California State Teachers Retirement System (CalSTRS) first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 8 quarters.
  • California State Teachers Retirement System (CalSTRS)'s VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $2.19M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q4 2016, filed 14 Feb 2017.